Stocks and InvestingStocks and Investing
Tue, January 30, 2024
Mon, January 29, 2024
Fri, January 26, 2024

Steven Seedhouse Upgraded (VERA) to Strong Buy and Increased Target to $37 on, Jan 26th, 2024


Published on 2024-10-28 08:35:26 - WOPRAI, Steven Seedhouse
  Print publication without navigation


Steven Seedhouse of Raymond James, Upgraded "Vera Therapeutics, Inc." (VERA) to Strong Buy and Increased Target from $29 to $37 on, Jan 26th, 2024.

Steven has made no other calls on VERA in the last 4 months.



There are 5 other peers that have a rating on VERA. Out of the 5 peers that are also analyzing VERA, 0 agree with Steven's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Steven


  • Justin Kim of "Oppenheimer" Initiated at Buy and Held Target at $26 on, Thursday, January 25th, 2024
  • Pete Stavropoulos of "Cantor Fitzgerald" Initiated at Buy on, Monday, January 8th, 2024
  • Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $25 on, Wednesday, December 27th, 2023
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $22 on, Thursday, November 30th, 2023
  • Farzin Haque of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $26 on, Friday, November 10th, 2023